1: Liang YH, Shen YQ, Guo W, Zhu YZ. SPRC protects hypoxia and re-oxygenation injury by improving rat cardiac contractile function and intracellular calcium handling. Nitric Oxide. 2014 Sep 15;41:113-9. doi: 10.1016/j.niox.2014.05.010. Epub 2014 Jun 2. PubMed PMID: 24887754.
2: Pan LL, Liu XH, Gong QH, Zhu YZ. S-Propargyl-cysteine (SPRC) attenuated lipopolysaccharide-induced inflammatory response in H9c2 cells involved in a hydrogen sulfide-dependent mechanism. Amino Acids. 2011 Jun;41(1):205-15. doi: 10.1007/s00726-011-0834-1. Epub 2011 Feb 10. PubMed PMID: 21308383.
3: Sidhapuriwala JN, Hegde A, Ang AD, Zhu YZ, Bhatia M. Effects of S-propargyl-cysteine (SPRC) in caerulein-induced acute pancreatitis in mice. PLoS One. 2012;7(3):e32574. doi: 10.1371/journal.pone.0032574. Epub 2012 Mar 1. PubMed PMID: 22396778; PubMed Central PMCID: PMC3291555.
4: Yang H, Mao Y, Tan B, Luo S, Zhu Y. The protective effects of endogenous hydrogen sulfide modulator, S-propargyl-cysteine, on high glucose-induced apoptosis in cardiomyocytes: A novel mechanism mediated by the activation of Nrf2. Eur J Pharmacol. 2015 Aug 15;761:135-43. doi: 10.1016/j.ejphar.2015.05.001. Epub 2015 May 12. PubMed PMID: 25979858.
5: Ma G, Zhang L, Zhang P, Bao X, Zhou N, Shi Q, Zheng Y, Liu H, Bu F, Zhang Y, Huang W, Wang F, Zhu Y, Cai W. Physicochemical characteristics and gastrointestinal absorption behaviors of S-propargyl-cysteine, a potential new drug candidate for cardiovascular protection and antitumor treatment. Xenobiotica. 2015 Apr;45(4):322-34. doi: 10.3109/00498254.2014.980369. Epub 2014 Nov 6. PubMed PMID: 25373426.
6: Li W, Ma F, Zhang L, Huang Y, Li X, Zhang A, Hou C, Zhu Y, Zhu Y. S-Propargyl-cysteine Exerts a Novel Protective Effect on Methionine and Choline Deficient Diet-Induced Fatty Liver via Akt/Nrf2/HO-1 Pathway. Oxid Med Cell Longev. 2016;2016:4690857. doi: 10.1155/2016/4690857. Epub 2016 May 22. PubMed PMID: 27313828; PubMed Central PMCID: PMC4893438.
7: Wen YD, Zhu YZ. The Pharmacological Effects of S-Propargyl-Cysteine, a Novel Endogenous H2S-Producing Compound. Handb Exp Pharmacol. 2015;230:325-36. doi: 10.1007/978-3-319-18144-8_16. Review. PubMed PMID: 26162842.
8: Liu C, Gu X, Zhu YZ. Synthesis and biological evaluation of novel leonurine-SPRC conjugate as cardioprotective agents. Bioorg Med Chem Lett. 2010 Dec 1;20(23):6942-6. doi: 10.1016/j.bmcl.2010.09.135. Epub 2010 Oct 7. PubMed PMID: 20980147.
9: Tran BH, Huang C, Zhang Q, Liu X, Lin S, Liu H, Wang S, Zhu YZ. Cardioprotective effects and pharmacokinetic properties of a controlled release formulation of a novel hydrogen sulfide donor in rats with acute myocardial infarction. Biosci Rep. 2015 Apr 30;35(3). pii: e00216. doi: 10.1042/BSR20140185. PubMed PMID: 26182378; PubMed Central PMCID: PMC4613708.
10: Le Pabic H, Germain-Amiot N, Bordeau V, Felden B. A bacterial regulatory RNA attenuates virulence, spread and human host cell phagocytosis. Nucleic Acids Res. 2015 Oct 30;43(19):9232-48. doi: 10.1093/nar/gkv783. Epub 2015 Aug 3. PubMed PMID: 26240382; PubMed Central PMCID: PMC4627067.
11: Kan J, Guo W, Huang C, Bao G, Zhu Y, Zhu YZ. S-propargyl-cysteine, a novel water-soluble modulator of endogenous hydrogen sulfide, promotes angiogenesis through activation of signal transducer and activator of transcription 3. Antioxid Redox Signal. 2014 May 20;20(15):2303-16. doi: 10.1089/ars.2013.5449. Epub 2014 Jan 30. PubMed PMID: 24180631; PubMed Central PMCID: PMC4005491.
12: Wu J, Guo W, Lin SZ, Wang ZJ, Kan JT, Chen SY, Zhu YZ. Gp130-mediated STAT3 activation by S-propargyl-cysteine, an endogenous hydrogen sulfide initiator, prevents doxorubicin-induced cardiotoxicity. Cell Death Dis. 2016 Aug 18;7(8):e2339. doi: 10.1038/cddis.2016.209. PubMed PMID: 27537522; PubMed Central PMCID: PMC5108313.
13: Rhodes RG, Nelson SS, Pochiraju S, McBride MJ. Flavobacterium johnsoniae sprB is part of an operon spanning the additional gliding motility genes sprC, sprD, and sprF. J Bacteriol. 2011 Feb;193(3):599-610. doi: 10.1128/JB.01203-10. Epub 2010 Dec 3. PubMed PMID: 21131497; PubMed Central PMCID: PMC3021240.
14: Zheng Y, Xu J, Ma G, Zhang J, Zhu Q, Liu H, Zhang P, Zhu Y, Cai W. Bioavailability and pharmacokinetics of S-propargyl-L-cysteine, a novel cardioprotective agent, after single and multiple doses in Beagle dogs. Xenobiotica. 2012 Mar;42(3):304-9. doi: 10.3109/00498254.2011.617848. Epub 2011 Oct 1. PubMed PMID: 21961645.
15: Wu WJ, Jia WW, Liu XH, Pan LL, Zhang QY, Yang D, Shen XY, Liu L, Zhu YZ. S-propargyl-cysteine attenuates inflammatory response in rheumatoid arthritis by modulating the Nrf2-ARE signaling pathway. Redox Biol. 2016 Dec;10:157-167. doi: 10.1016/j.redox.2016.08.011. Epub 2016 Oct 6. PubMed PMID: 27744121; PubMed Central PMCID: PMC5066299.
16: Ma K, Liu Y, Zhu Q, Liu CH, Duan JL, Tan BK, Zhu YZ. H2S donor, S-propargyl-cysteine, increases CSE in SGC-7901 and cancer-induced mice: evidence for a novel anti-cancer effect of endogenous H2S? PLoS One. 2011;6(6):e20525. doi: 10.1371/journal.pone.0020525. Epub 2011 Jun 27. PubMed PMID: 21738579; PubMed Central PMCID: PMC3124470.
17: Qian X, Li X, Ma F, Luo S, Ge R, Zhu Y. Novel hydrogen sulfide-releasing compound, S-propargyl-cysteine, prevents STZ-induced diabetic nephropathy. Biochem Biophys Res Commun. 2016 May 13;473(4):931-8. doi: 10.1016/j.bbrc.2016.03.154. Epub 2016 Apr 4. PubMed PMID: 27055593.
18: Choi EY, Oh EA, Kim JH, Kang DK, Hong SK. Distinct regulation of the sprC gene encoding Streptomyces griseus protease C from other chymotrypsin genes in Streptomyces griseus IFO13350. J Microbiol Biotechnol. 2007 Jan;17(1):81-8. PubMed PMID: 18051357.
19: Zheng YT, Zhu JH, Ma G, Zhu Q, Yang P, Tan B, Zhang JL, Shen HX, Xu JL, Zhu YZ, Cai WM. Preclinical assessment of the distribution, metabolism, and excretion of S-propargyl-cysteine, a novel H2S donor, in Sprague-Dawley rats. Acta Pharmacol Sin. 2012 Jun;33(6):839-44. doi: 10.1038/aps.2012.15. Epub 2012 Apr 30. PubMed PMID: 22543704; PubMed Central PMCID: PMC4010370.
20: Wang W, Cheng J, Zhu Y. The JNK Signaling Pathway Is a Novel Molecular Target for S-Propargyl- L-Cysteine, a Naturally-Occurring Garlic Derivatives: Link to Its Anticancer Activity in Pancreatic Cancer In Vitro and In Vivo. Curr Cancer Drug Targets. 2015;15(7):613-23. PubMed PMID: 26033085.